AI-powered pathology platform that assists with cancer diagnosis and biomarker analysis
PathAI is a leading AI platform that transforms pathology and cancer diagnosis through machine learning-powered tissue analysis. The platform assists pathologists in detecting cancer, analyzing biomarkers, and improving diagnostic accuracy while reducing turnaround times. PathAI's algorithms are trained on millions of pathology images and can identify subtle patterns that might be missed by human analysis alone. The platform is designed to augment pathologist expertise rather than replace it, providing AI-powered insights that support more accurate and consistent diagnoses. PathAI is used by major pharmaceutical companies, hospitals, and research institutions to advance precision medicine and improve patient outcomes.
Machine learning algorithms trained to detect various cancer types in tissue samples
Use Case:
Assist pathologists in identifying early-stage cancers that might be difficult to detect manually
Automated analysis of biomarkers for personalized treatment selection
Use Case:
Identify patients who would benefit from specific targeted cancer therapies
Standardize pathology analysis to reduce variability between different pathologists
Use Case:
Ensure consistent cancer grading and staging across different medical centers
Tools for pharmaceutical companies to analyze tissue samples in clinical trials
Use Case:
Accelerate drug development by providing consistent biomarker analysis in cancer trials
Pricing information is available on the official website.
View Pricing →Ready to get started with PathAI?
View Pricing Options →Weekly insights on the latest AI tools, features, and trends delivered to your inbox.
Get started with PathAI and see if it's the right fit for your needs.
Get Started →Take our 60-second quiz to get personalized tool recommendations
Find Your Perfect AI Stack →